Introduction
The optimal management of adenocarcinoma-in-situ (AIS) of the uterine cervix after conservative treatment with cold knife cone biopsy (CKC) or loop electrosurgical excision procedure (LEEP) remains controversial (1) (2) (3) (4) . Positive or close histopathological margins are associated with an increased risk of AIS persistence and recurrence (1, 2, (5) (6) (7) (8) (9) , but whether hysterectomy should be performed as definitive treatment in margin-negative AIS remains uncertain (4, (10) (11) (12) . To date there have been conflicting reports regarding the rates of subsequent cervical neoplasia in these women (1, 2, (4) (5) (6) (7) 13) .
Until very recently Australian management guidelines recommended hysterectomy as definitive treatment following CKC for AIS, once childbearing had been completed (14) . Hysterectomy was recommended due to the limitations of cytological follow up, the risk of recurrence, and the potential multifocality of the disease (14) . These management recommendations have recently undergone extensive review, and new draft clinical management guidelines for the prevention of cervical cancer have been proposed (15) . These suggest that all women with clear margins (regardless of desirability of fertility) who have been treated for AIS by an excisional procedure will no longer require hysterectomy as a definitive treatment (15) . Women conservatively treated for AIS will now be followed up with a "test of cure" using annual co-testing [high-risk (HR) human papillomavirus (HPV) and liquid based cytology], which will ensure intensive surveillance. Until further follow-up information is available, women will need to be screened annually for an indefinite period (15) .
This aim of the present study was to investigate the risk of persistent or recurrent cervical neoplasia in a Western Australian (WA) cohort of conservatively treated women with negative histopathological margins and compliance with follow-up recommendations.
Material and methods

Data sources and linkages
The legislatively mandated Western Australian Cervical Screening Registry has recorded all cervical test results (HPV, cytology and histology) for WA residents since 1991. As an "opt off" register, it captures over 99.5% of the state's cervical screening data (2) .
Through the use of the well described WA Data Linkage System (16) (17) (18) 
Histopathology findings
All histopathology reports were reviewed to confirm the type of excisional biopsy (CKC biopsy or LEEP), the number of surgical specimens, depth of the specimen, presence of concurrent high-grade cervical squamous intraepithelial neoplasia (CIN) and resection margin status. The number of surgical specimens was classified as 1 or >1, the latter including both intentional two-stage procedures (LEEP followed by "top hat" endocervical sampling) as well as technically difficult procedures which
Key Message
Women who are treated conservatively for adenocarcinoma-in-situ and have negative histological margins, must be encouraged and supported to comply with annual follow-up recommendations as there is a low but significant risk of high-grade persistent/recurrent cervical disease. resulted in multiple, fragmented or incomplete specimens. Margin status was considered "positive" if any margin (ectocervical, endocervical or deep/circumferential) was involved with AIS, "negative" if all margins were histologically clear of AIS, or "indeterminate" if margins could not be assessed or were not documented. The extent of AIS was determined whenever possible from the initial histopathology reports in one of two ways. In some specimens, the maximal microscopically measured extent of AIS was specifically documented, whereas in other cases the number of tissue blocks demonstrating AIS was recorded; in the latter situation, AIS extent was estimated assuming a "standard" block width of 2.5 mm multiplied by the total number of involved blocks. In the event that the lesion size and/or number of positive blocks was not reported, the specimens were recorded as "lesion size not reported." For those cases with reported AIS extent, the lesion size was categorized as (i) <1.5 mm, (ii) ≥1.5 to
Compliance with follow-up recommendations
Subsequent follow up of women potentially included cervical cytology, HPV testing, punch biopsy, repeat CKC or LEEP biopsy and/or hysterectomy. The follow-up period was defined as the date of the initial excisional procedure to the date of the last follow-up procedure (such as cervical cytology, biopsy, hysterectomy or vault smear) or death.
Principal outcomes
The principal outcomes were persistence of AIS, high-grade CIN and/or a diagnosis of adenocarcinoma during the follow-up or surveillance periods (defined as <12 months or ≥12 months after initial diagnosis, respectively).
Statistical analyses
Proportional hazards models to investigate the relative rate (hazard ratio) of subsequently developing a highgrade cervical lesion post initial treatment were constructed using purposeful selection of the following covariates: age at treatment, type of excisional procedure (CKC biopsy or LEEP), margin status, lesion size, and depth of excised tissue. Statistical significance was determined as a p-value <0.05 and the 95% confidence intervals (CI) for hazard rate ratios were calculated. Violation of the proportional-hazard assumptions was assessed and biologically plausible interaction terms between variables were tested. STATA/IC 13.0 (StataCorp, College Station, TX, USA) was used for statistical analysis.
Results
Study cohort
During the study period, 721 women had a histopathological diagnosis of AIS confirmed on CKC or LEEP surgical specimens. In all, 683 women underwent conservative excisional treatment for AIS, and 360 were confirmed to have six months of follow up and negative margins in their treatment specimens (Figure 1) . The median patient age at time of treatment was 30.0 years (range 18-64 years) and the median follow-up interval was 3.9 years (range six months to 12.2 years). Baseline patient demographic and clinicopathological characteristics are shown in Table 1 .
AIS lesion size could be ascertained in 209 (58.1%) cases (Table 1 ) of which 132 were directly measured and 77 determined from the number of involved blocks. The median lesion size was 3 mm (range 0.5-26.0 mm) ( Table 1) . Second excisional procedures were performed in 89 women during follow up and their histopathological findings are shown in Table 2 .
Follow-up period (<12 months post treatment)
In the 12 months following the initial CKC or LEEP biopsy, 54 (15%) women had a second excisional procedure (eight were LEEP, 12 were CKC and 34 were a hysterectomy). Of these 54 women, 37 had negative findings, six had low-grade changes, one had CIN 2/3, nine had AIS, and one had invasive adenocarcinoma (shown in Table 2 ). The patient diagnosed with invasive adenocarcinoma had a CKC biopsy performed initially which was submitted as a single specimen, was pure AIS (CIN was not present) and was extensive. Within 12 months the patient underwent a hysterectomy that confirmed the presence of a small focus of early stromal invasion by adenocarcinoma. The patient has had follow-up vault smears performed over a four-year period that were reported as negative. Of the 54 women that underwent a second excisional procedure, a further four women then had a subsequent hysterectomy performed in the followup period (all four cases were confirmed negative). The median age at time of hysterectomy was 38 years.
Surveillance period (≥12 months post treatment)
After excluding the 54 women who were treated with a second excisional procedure during the follow-up period, 306 women entered the surveillance period. Of these 306 women, 35 (11.4%) underwent a second excisional procedure (five were LEEP and two were CKC) or hysterectomy (n = 28). Negative findings were recorded in 28 women, four had low-grade changes, two had CIN 2/ 3 and one had recurrent AIS. A further 23 women had a cervical punch biopsy performed (18 cases were negative, four showed low-grade changes and one showed CIN 3). Two women had a subsequent hysterectomy, both with negative histological findings. The remaining 248 women underwent cytological surveillance, which was negative in 199 women, showed low-grade abnormalities in 39 women, possible high-grade squamous intraepithelial lesion in six women, and AIS in four women. Overall, seven (1.9%) women had CIN 2/3 (six of these cases had CIN coexisting with AIS on initial excisional specimen), 10 (2.8%) had AIS and one (0.3%) had adenocarcinoma diagnosed during the follow-up and surveillance periods. 
Compliance with follow-up recommendations after conservative AIS treatment
Although the 2005 Australian National Health and Medical Research Council Guidelines did not specifically recommend the "test of cure" for the follow up of women treated conservatively for AIS, 61 women had an initial co-test (HR HPV testing and cervical cytology) performed as part of their follow-up care. Of these, 25 women successfully completed the "test of cure" (co-testing at 12 and 24 months post-treatment) and no high-grade cervical abnormality or cancer was detected in these women. There were 15 women who had initial co-testing, but subsequent cytology only. A further 14 women had one set of co-tests but follow-up data were not available in 10 cases and four women underwent hysterectomy. A persistent low-grade abnormality was identified in four women who returned to six-monthly cytology surveillance; one of these women had a subsequent diagnosis of CIN3 but no high-grade abnormality was detected for the remaining three women. Co-testing was performed in two women following hysterectomy but these women had no further cytological examination.
Hysterectomy
In this study (follow-up and surveillance periods) 68 women underwent hysterectomy as definitive treatment of AIS. The majority of women (n = 56) had negative histological findings but CIN 2 was present in one case, AIS in five cases, and one patient had cervical adenocarcinoma.
Significant factors associated with disease persistence and recurrence
Overall, no patient characteristics or clinicopathological factors (age at excisional treatment (hazard ratio 4.8; 95% CI 0.9-25.6; p-value 0.069), Socio Economic Indexes for Areas, excisional treatment type (hazard ratio 0.4; 95% CI 0.1-1.8, p-value 0.253), lesion size, presence of concurrent highgrade CIN (hazard ratio 1.9; 95% CI 0.5-7.1; p-value 0.348) or number of surgical specimens (hazard ratio 3.1; 95% CI 0.5-18.7; p-value 0.226) were identified as statistically significant predictors of disease persistence at 12 months or recurrence during a median follow up of 3.9 years.
Discussion
In this study of conservatively treated women with AIS and negative histopathological margins, there was a 3.1% risk of persistent or recurrent high-grade cervical neoplasia at a median follow up of 3.9 years. In a multivariate model including age, type of excisional procedure, lesion size, and depth of excised tissue, there were no significant predictors of AIS persistence or recurrence. Following the diagnosis of AIS, women wishing to preserve fertility may opt for conservative treatment but it is important that these women are aware of the potential risks of residual or recurrent cervical neoplasia. Positive or close histopathological margins are associated with an increased risk of disease recurrence, but the risk in women with histologically negative margins is less clear, as earlier studies have demonstrated conflicting results. These studies have also been limited by single institutional reviews or small sample size.
Limitations of the current study include the retrospective design, absence of centralized pathology review and relatively short median follow-up period. Although this is the largest population-based study of AIS ever reported, the small number of events observed (cases of recurrent cervical neoplasia) during follow up may explain why no demographic, clinical or pathological factors were significant predictors of disease persistence or recurrence on multivariate modeling. Strengths of the study are its large population-based cohort and data linkage.
In many countries, following excisional biopsy to exclude cervical adenocarcinoma, hysterectomy remains the recommended definitive treatment of AIS (10, 20) . Overall, 19% of women in the current study underwent hysterectomy during follow up. Five of these women had AIS and one had adenocarcinoma; therefore approximately 9% of women undergoing hysterectomy had in situ or invasive endocervical adenocarcinoma.
Recently, new management guidelines have recommended that HR HPV testing in conjunction with cervical cytology be performed indefinitely following conservative treatment for AIS. Although only 6.9% of women in this study completed the "test of cure" pathway following conservative treatment of AIS, it was encouraging that none of these women tested positive for HR HPV or had abnormal cervical cytology during their subsequent screening. The low number of women that underwent the "test of cure" is not surprising, given it is not a current follow-up recommendation for the surveillance of these women in Australia. As Australia moves into a new evidence-based cervical screening program that uses primary HPV testing for all women (21), it will be critical to support and enhance clinicians' understanding of this test. HR HPV testing in conjunction with cervical screening will play a critical role in the surveillance of women who were conservatively treated for high-grade cervical abnormalities and in the overall prevention of cervical cancer.
In conclusion, women treated conservatively for AIS with negative margins should be counseled regarding the risks of residual disease and recurrence, and should undergo long-term surveillance indefinitely. Women who are unable to comply with ongoing annual co-testing (HR HPV testing and cervical cytology) should be offered definitive treatment with hysterectomy once childbearing is complete.
